Analyst Ratings for Medpace (MEDP)
MEDP Rating Summary
MEDP Price Target Summary
- Highest: $560.00 (Jefferies)
- Lowest: $305.00 (UBS)
- Average: $455.55
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$455.55 (-1%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$455.55 (-1%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Barclays » Updated 4/24/2026 |
Luke Sergott | Upgrade | Equalweight (Underweight) |
450.00 (500.00) |
469.38 (460.20) |
-1.96% | Details |
| 3/3/2026 | RBC Capital » Updated 4/24/2026 |
Ryan Halsted | New Coverage | Outperform (N/A) |
484.00 (522.00) |
451.76 (460.20) |
1.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
